Results 181 to 190 of about 362,095 (261)

Smart, Bio‐Inspired Polymers and Bio‐Based Molecules Modified by Zwitterionic Motifs to Design Next‐Generation Materials for Medical Applications

Advanced Functional Materials, EarlyView.
Bio‐based and (semi‐)synthetic zwitterion‐modified novel materials and fully synthetic next‐generation alternatives show the importance of material design for different biomedical applications. The zwitterionic character affects the physiochemical behavior of the material and deepens the understanding of chemical interaction mechanisms within the ...
Theresa M. Lutz, Jonas De Breuck, Sahar Salehi, Meike N. Leiske   +3 more
wiley   +1 more source

Conceptual model of pharmaceutical care for patients with coronary heart disease and comorbid conditions in Ukraine. [PDF]

J Pharm Policy Pract
Bilousova N.
europepmc   +1 more source

The CMO System Model: A Dynamic Framework to Operationalize Adaptive Pharmaceutical Care and Drive Health-System Sustainability [PDF]

Ramón A Morillo-Verdugo, Maria Romero Murillo, Cecilia Solís-Martín, Enrique Contreras-Macías   +3 more
openalex   +1 more source

Emerging 2D Materials and Their Hybrid Nanostructures for Label‐Free Optical Biosensing: Recent Progress and Outlook

Advanced Functional Materials, EarlyView.
This review highlights recent advances in label‐free optical biosensors based on 2D materials and rationally designed mixed‐dimensional nanohybrids, emphasizing their synergistic effects and novel functionalities. It also discusses multifunctional sensing platforms and the integration of machine learning for intelligent data analysis.
Xinyi Li, Yonghao Fu, Yuehe Lin, Dan Du
wiley   +1 more source

Impact of collaborative pharmaceutical care on older inpatients' medication safety: multicentre stepped-wedge cluster randomised trial (MEDREV Study). [PDF]

BMC Geriatr
Leguelinel-Blache G, Bouvet S, Bedouch P, Bachelet B, Chenailler C, Dantin T, Geneletti L, Janes A, Scher F, Cireașă B, Kinowski JM, Castelli C, Roux-Marson C, Working Group “Valorisation of Pharmacist Interventions” of the French Society of Clinical Pharmacy, MEDREV working group.   +14 more
europepmc   +1 more source

Harnessing Non‐Covalent Protein–Protein Interaction Domains for Production of Biocatalytic Materials Systems

Advanced Functional Materials, EarlyView.
Non‐covalent protein–protein interactions mediated by SH3, PDZ, or GBD domains enable the self‐assembly of stable and biocatalytically active hydrogel materials. These soft materials can be processed into monodisperse foams that, once dried, exhibit enhanced mechanical stability and activity and are easily integrated into microstructured flow ...
Julian S. Hertel, Maria Alessandra Martini, Marius Stoeckle, Annika J. Weber, Kersten S. Rabe, Christof M. Niemeyer   +5 more
wiley   +1 more source

The impact of early pregnancy disease control in systemic lupus erythematosus patients receiving comprehensive pharmaceutical care on pregnancy outcomes and offspring long-term health. [PDF]

BMC Pregnancy Childbirth
Zheng L, Yu X, Li S, Huang J, He Y, Zhang L, Xia X, Zhu J, Yue J, Wang Y, Zhuang Y, Zhou C, Wu Y.   +12 more
europepmc   +1 more source

Priority Setting and Influential Factors on Acceptance of Pharmaceutical Recommendations in Collaborative Medication Reviews in an Ambulatory Care Setting – Analysis of a Cluster Randomized Controlled Trial (WestGem-Study)

, 2016
Olaf Rose, Hugo Mennemann, Carina John, Marcus Lautenschläger, Damaris Mertens-Keller, Katharina Richling, Isabel Waltering, Stefanie Hamacher, Moritz Felsch, Lena Herich, Kathrin Czarnecki, Corinna Schaffert, Ulrich Jaehde, Juliane Köberlein–Neu   +13 more
openalex   +2 more sources

Unleashing the Power of Machine Learning in Nanomedicine Formulation Development

Advanced Functional Materials, EarlyView.
A random forest machine learning model is able to make predictions on nanoparticle attributes of different nanomedicines (i.e. lipid nanoparticles, liposomes, or PLGA nanoparticles) based on microfluidic formulation parameters. Machine learning models are based on a database of nanoparticle formulations, and models are able to generate unique solutions
Thomas L. Moore, Cristiano Pesce, Antonietta Greco, Claudia Pisante, Greta Avancini, Valentina Di Francesco, Yosi Shamay, Paolo Decuzzi   +7 more
wiley   +1 more source